GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of someone explain pharmacy to me like I have not read a paper in years — 17 comments in the full submission. View in context.
121
c/glp1eu·submitted 1 year ago by u/erez_yilmaz

someone explain pharmacy to me like I have not read a paper in years

Pricingbranch of 6 comments

someone explain pharmacy to me like I have not read a paper in years. If this has been answered properly somewhere, link me and I will delete. On cross-border prescriptions, since the assumption behind half these threads is wrong. There are EU rules on the recognition of prescriptions issued in another member state,…

Read the full submission and all 17 comments →

This branch

6 comments, started 1 year ago
u/nordic_pricingMOD15 points·1 year ago

Pointing this one at a pharmacist locally. Eligibility questions have national answers we cannot give.

replysharereportpermalink
u/sten_bhattacharya7 points·1 year ago

reimbursement is national, not European, and that is the whole board

replysharereportpermalink
u/rohan_steiner9 points·1 year ago

reimbursement is national, not European, and that is the whole board

sten_bhattacharya is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/vikram_asante6 points·1 year ago

This. The published reimbursement criteria are the document to read, and most member states do publish them.

replysharereportpermalink
u/cesar_oyelaran3 points·1 year ago

pack sizes differ, so per-month comparisons need care

replysharereportpermalink
u/patient_labslip_log1 point·1 year ago

ask for the Beipackzettel or the local equivalent, it answers most questions

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.